SCHEMBL4048041

SCHEMBL4048041

c1cnc2[nH]c(CC3CCC3)nc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBK Q96KB5 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
PDE9A O76083 5/20 0.37
CCNB2 O95067 3/20 0.37
CDK1 P06493 3/20 0.37
CCNB1 P14635 3/20 0.37
GSK3A P49840 3/20 0.37
GSK3B P49841 3/20 0.37
CCNB3 Q8WWL7 3/20 0.37
UTS2R Q9UKP6 1/20 0.35
METAP2 P50579 1/20 0.35
METAP1 P53582 1/20 0.35
IDO1 P14902 1/20 0.33
DGAT2 Q96PD7 1/20 0.33
ITK Q08881 1/20 0.33
PDE5A O76074 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040136 0.97 AAK1 (0.43) PBKAAK1PDE9ACCNB2CDK1
SCHEMBL4051351 0.95 PDE9A (0.42) PBKAAK1PDE9ACCNB2CDK1
SCHEMBL4047661 0.93 PBK (0.42) PBKAAK1PDE9ACCNB2CDK1
SCHEMBL4046851 0.84 LMNA (0.34) PBKCCNB2CDK1CCNB1GSK3A
SCHEMBL4055775 0.81 LMNA (0.36) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL4056218 0.80 LMNA (0.39) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL4046994 0.71 ADORA1 (0.42) CDK1CCNB1GSK3AGSK3BMETAP2
SCHEMBL4059999 0.70 METAP2 (0.38) PBKMETAP2METAP1ADORA2AADORA2B
SCHEMBL4052252 0.68 KDM4C (0.41) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL4054581 0.67 ADORA1 (0.40) PBKMETAP2METAP1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed